New federal rule requires drug intermediaries to disclose how they’re paid

The Trump administration released a final rule Thursday requiring pharmacy benefit managers to disclose all payment methods to clients. The Department of Labor rule targets companies managing billions in prescription drug spending for employers and workers, mandating transparency in how PBMs are compensated. The regulation takes effect following standard federal procedural timelines.